CC
IBRX icon

Courier Capital’s ImmunityBio IBRX Stock Holding History

Courier Capital’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$430K Hold
56,000
– – 0.02% 292
2025
Q4 		$111K Buy
56,000
+6,000
+12% +$13.6K 0.01% 381
2025
Q3 		$123K Buy
50,000
+5,000
+11% +$12.9K 0.01% 387
2025
Q2 		$119K Buy
45,000
+5,000
+13% +$13.4K 0.01% 382
2025
Q1 		$120K Buy
40,000
+10,000
+33% +$30.3K 0.01% 370
2024
Q4 		$76.8K Hold
30,000
– – 0.01% 359
2024
Q3 		$112K Buy
30,000
+10,000
+50% +$46.3K 0.01% 356
2024
Q2 		$126K Hold
20,000
– – 0.01% 337
2024
Q1 		$107K Buy
20,000
+5,000
+33% +$22.6K 0.01% 356
2023
Q4 		$75.3K Buy
+15,000
New +$47.1K 0.01% 354

Other funds holding IBRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return